5G in Healthcare Market by Component (Hardware, Connectivity, Services) Application (Remote Patient Monitoring, Connected Medical Devices, AR/VR, Connected Ambulance, Asset Tracking) End User (Healthcare Providers, Payers) & Region - Global Forecast to 2026
The global 5G in Healthcare Market in terms of revenue was estimated to be worth $215 million in 2021 and is poised to reach $3,667 million by 2026, growing at a CAGR of 76.3% from 2021 to 2026. The increasing adoption of telehealth and robotics surgery due to COVID-19 and the rising adoption of 5G-enabled wearable medical devices for real-time remote patient monitoring are key factors driving the growth of this market. The ability of 5G technology to transmit large patient data files quickly, advancements in telecommunication, and the availability of low-cost sensors are other major factors that are driving the growth of this market. However, the high cost of deployment of the 5G network is expected to restrain the growth of this market.
In this report, the 5G in healthcare market is segmented into component, application, end user, and region.
5G stands for the fifth generation of mobile communication technology. With each generation’s new technology and standards, there have been improvements in transmission speed and network capacity. 5G represents a big leap in cellular technology and in healthcare by providing essential levels of connectivity to enable a new health ecosystem, one that can meet the needs of patients and providers accurately, efficiently, cost-effectively, conveniently, and at a substantial scale. This massive network will include billions of low-bitrates and low-energy connected health monitoring devices, remote sensors, and clinical wearables, with 5G providing a backbone infrastructure for IoT.
To know about the assumptions considered for the study, Request for Free Sample Report
5G in Healthcare Market Dynamics
Drivers: Increasing adoption of telehealth and robotics surgery due to COVID-19
ICT and medical expertise have been a powerful combination for enhancing patient care for many years. Remote diagnosis and robotic-assisted surgery are commonly used across the globe, and the rapid pace at which ICT is evolving means that even greater possibilities for these techniques are becoming a reality.
Telemedicine requires a network that can support real-time high-quality video, which often means wired networks. According to a report by Frost & Sullivan, telehealth will grow sevenfold by 2025, with a compounded annual growth rate of 38.2%, parallel with the emergence and rollout of 5G.
Several countries have shown growing support for telemedicine and telehealth and are beginning to establish statewide telehealth coverage, defined reimbursement policies, and a legal framework for telehealth practices. For instance, in April 2019, the Centers for Medicare & Medicaid Services (CMS) announced and finalized changes in Medicare’s telehealth policy to enable remote patient monitoring for patients to access the latest technology and improve the coordination of healthcare processes. Furthermore, due to the pandemic, healthcare delivery changed significantly. Hospitals and doctors’ offices became potential exposure zones with patients needing urgent care. As a result, telemedicine became the primary option for patients needing care. The high standard of virtual care, coupled with the presence of 5G and its significant potential, healthcare delivery will transform to great levels. In the aftermath of the coronavirus pandemic, the 5G Enhanced Mobile Broadband (eMBB) technology?will enable remote support of quality healthcare while reducing patient exposure to contagion by minimizing in-person visits to doctor or healthcare facilities. For patients who cannot easily travel to their healthcare providers, 5G will allow the provider to visit them via telepresence systems.
Robotic-assisted laser surgery is another area that can benefit from such developments. With the aid of a machine, doctors can now perform complex procedures with greater precision and flexibility and minimize the invasiveness of the operation. This is possible through 5G technology, which has helped in advances in software and seamless transmission of information. Many telecom giants are adopting this technology to transform their healthcare systems. For instance, in November 2019, Vodafone conducted a remote surgery operation for the first time in Italy through a live 5G network in collaboration with the Italian Institute of Technology (IIT) and the IRCSS Hospital San Raffaele. The surgery was performed from the theatre stage of the Vodafone Village, owing to benefits like extremely low latency and a high degree of reliability provided by 5G. This gives us a future outlook of healthcare, making medical and surgical expertise available on an ever-greater scale and eliminating geographical barriers. The benefits provided by 5G have further added to the increasing adoption of telehealth solutions.
Restraints: High cost of deployment of the 5G network
The transition from 4G to 5G technology would result in huge investments. The cost of the 5G infrastructure depends heavily on the required throughput density, periodic interest rate, and base station price. The reduction of these costs is important for effective and ultra-dense small cell deployments. The challenge for CSPs in transitioning to 5G is to justify the multibillion dollars of investments in new network equipment required to transform their network to a virtualized infrastructure, move services from 3G and 4G to 5G, all while protecting their business against the ever-increasing risks of disruptions and cyber threats. The transition to a standalone model is essential for telcos to capitalize on the full range of benefits that 5G offers. Their ability to successfully capture enterprise customers with low latency applications will require a distributed, standalone network with an edge compute platform, network slicing, and control/user plane separation. The current standalone deployments have helped telcos quickly work upon their 5G rollout plans that are focused on delivering fixed and mobile broadband services to consumers.
Opportunities: Role of AI in 5G healthcare
An AI-powered, real-time remote monitoring solution enables caregivers to passively detect changes in conditions, reduce hospitalizations, and improve quality metrics. AI and 5G-enabled devices track users’ daily living activities using novel gesture-detection algorithms and provide insights and predictive analytics around them, including sleep quality, fall risk, fall detection, drinking/hydration, activity patterns, wandering, and UTI risk. These data deliver important clinical insights to healthcare providers, helping them maintain continuous contact with and improve the well-being of those under their care. Internet of Things (IoT)-enabled medical devices and AI-powered data analysis can streamline health monitoring and create a fully “connected” hospital. IoT can also aid in driving greater efficiencies in auxiliary functions such as logistics and supply chain.
Apps and wearables based on AI can leverage 5G and machine learning for health-related data analysis of medical diagnosis and emergency care. Many key healthcare functions are beginning to use artificial intelligence (AI) to determine potential diagnoses and decide on the best treatment plan for a specific patient. Additionally, AI can help predict which patients are more likely to have postoperative complications, allowing healthcare systems to provide early interventions when necessary. By moving to 5G networks, healthcare organizations can use the AI tools they need to provide the best care possible.
Challenges: Data breach and security concerns
Increased use of automated healthcare technologies offers greater reach and efficiency in healthcare delivery but has high-security risks due to the broader access offered. Approximately one-third of data breaches result in medical identity theft in the healthcare industry, mainly due to the lack of internal control over patient information, outdated policies and procedures or non-adherence to existing ones, and inadequate personnel training.
5G brings together applications that are dependent on data moving very quickly in a real-time environment. However, it is not just about faster speeds to the smartphone; it is about connecting devices and machines to each other. But integrating these devices to one another comes with its own set of concerns.
In the US, the HIPAA Journal recorded 616 healthcare data breaches in its 2020 breach list, an increase of 66% over the total number of breaches tracked in 2018. According to a publication from HIPAA Journal, HIPAA-covered companies and business associates paid around USD 13.6 million for HIPAA violations in 2020 and around USD 15.3 million in 2019. Thus, creating a secure communication platform is a major challenge faced by IT vendors catering to the healthcare industry. Potential security concerns related to healthcare IT systems may lead to a rise in the sense of insecurity among users and, hence, restrict their adoption until secure 5G related solutions are available in the market.
“The Hardware segment accounted for the largest market share in 2020.”
Based on component, the 5G in healthcare market is segmented into hardware, services, and connectivity. The hardware segment accounted for the largest share of the 5G in healthcare market in 2020. This segment is projected to reach USD 1,871.7 million by 2026, at a CAGR of 76.0% during the forecast period. The large share of this segment can primarily be attributed to the need for frequent upgradation or replacement to make optimal use of the latest software available in the market.
“The Connected Medical Devices segment accounted for the largest market share in 2020.”
Based on application, the 5G in healthcare market is segmented into remote patient monitoring, connected ambulance, connected medical devices, asset tracking for medical devices, and AR/VR. The connected medical devices segment accounted for the largest share of the 5G in healthcare market in 2020. This application segment is projected to reach USD 1,405.3 million by 2026 from USD 94.5 million in 2021, at a CAGR of 71.6% during the forecast period. The large share of this segment can be attributed to the growth in the telehealth market and the growing inclination towards home healthcare. The high burden of COVID-19, increasing healthcare costs, strong government support and initiatives, and the growing focus on the quality of care and patient safety are further driving the market for connected medical devices in the 5G in healthcare market.
“The Healthcare Providers segment accounted for the largest market share in 2020.”
Based on end users, the 5G in healthcare market is segmented into healthcare providers, healthcare payers, and other end users. The healthcare providers segment accounted for the largest share of the 5G in healthcare market in 2020. This end-user segment is projected to reach USD 3,011.1 million by 2026 from USD 170.4 million in 2021, at a CAGR of 77.6% during the forecast period. The large share of this segment can be attributed to the rising need for an efficient healthcare system, growing patient volume, increasing number of hospitals and ambulatory care centers, growth in telehealth, rising adoption of 5G-enabled wearable medical devices, and the rising demand for better technologies that help in the easy transfer of large data files.
“Asia Pacific was the largest regional market for 5G in healthcare market in 2020“
The global 5G in healthcare market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, Asia Pacific accounted for the largest share of 33.8% of the global market. The APAC is the largest and fastest-growing region in the 5G in healthcare market. This growth can be attributed to the significant adoption of advanced technologies, increasing number of IoT-enabled medical devices, continuously enhancing network connectivity, and government initiatives for IoT.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
Prominent players in the 5G in healthcare market include AT&T (US), Verizon (US), China Mobile Limited (China), T-Mobile (US), Ericsson (Sweden), Telit (Poland), Telus (Canada), Vodafone (UK), Nokia (Finland), Samsung (South Korea), Deutsche Telekom AG (Germany), Orange S.A. (France), SK Telecom Co., Ltd. (South Korea), BT Group (UK), NTT DOCOMO (UK), NEC Corporation (Japan), Telefónica (Spain), Airtel (India), Huawei Technologies Co., Ltd. (China), Cisco (US), Sierra Wireless (Canada), Swisscom (Switzerland), Qualcomm (US), Fibocom Wireless Inc. (China), Quectel (China), and Sequans (France) These companies adopted strategies such as service launches, expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their market presence in the 5G in healthcare market.
5G in Healthcare Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$215 million |
|
Estimated Value by 2026 |
$3,667 million |
|
Growth Rate |
poised to grow at a CAGR of 76.3% |
|
Largest Share Segments |
Hardware Segment, Connected Medical Devices & Healthcare Providers |
|
Market Report Segmentation |
Component, Application, End User & Region |
|
Growth Drivers |
|
|
Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
The study categorizes the 5G in healthcare based on By Component, Application and End User at the regional and global level.
By Component
- Hardware
- Services
- Connectivity
By Application
- Connected Medical Devices
- Remote Patient Monitoring
- AR/VR
- Asset tracking for medical devices
- Connected Ambulance
By End Users
- Healthcare Providers
- Healthcare Payers
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Recent Developments
- In January 2019, Rush University Medical Center partnered with AT&T (US) to bring the latest mobile communications technology to clinical care based on 5G to improve communications, data processing needs, and the patient experience.
- In May 2019, Ooredoo (Qatar) worked with Ericsson (Sweden) to leverage 5G technology in ambulances to allow doctors to treat patients remotely by controlling a special haptic glove worn by the paramedic on the scene.
- In February 2020, Emory Healthcare partnered with Verizon (US). Emory Healthcare is using Verizon’s 5G Ultra-Wideband to enhance augmented reality and virtual reality (AR/VR) applications for medical training, telemedicine, and remote monitoring, in addition to diagnostic and imaging systems from ambulances to ER.
- In January 2020, China Telecom (China), ZTE (China), and West China hospital are facilitating the remote diagnosis of coronavirus via 5G.
- In June 2020, ZTE (China), along with Huawei (China), built 5G demo sites for remote consultation and outpatient & image diagnosis.
Frequently Asked Questions (FAQs):
What is the size of 5G in Healthcare Market?
The global 5G in Healthcare Market in terms of revenue was estimated to be worth $215 million in 2021 and is poised to reach $3,667 million by 2026, growing at a CAGR of 76.3% from 2021 to 2026.
Why is 5G in Healthcare Market Growing ?
The increasing adoption of telehealth and robotics surgery due to COVID-19 and the rising adoption of 5G-enabled wearable medical devices for real-time remote patient monitoring are key factors driving the growth of this market. The ability of 5G technology to transmit large patient data files quickly, advancements in telecommunication, and the availability of low-cost sensors are other major factors that are driving the growth of this market. However, the high cost of deployment of the 5G network is expected to restrain the growth of this market.
Who all are the prominent players of 5G in Healthcare Market?
Prominent players in the 5G in healthcare market include AT&T (US), Verizon (US), China Mobile Limited (China), T-Mobile (US), Ericsson (Sweden), Telit (Poland), Telus (Canada), Vodafone (UK), Nokia (Finland), Samsung (South Korea), Deutsche Telekom AG (Germany), Orange S.A. (France), SK Telecom Co., Ltd. (South Korea), BT Group (UK), NTT DOCOMO (UK), NEC Corporation (Japan), Telefónica (Spain), Airtel (India), Huawei Technologies Co., Ltd. (China), Cisco (US), Sierra Wireless (Canada), Swisscom (Switzerland), Qualcomm (US), Fibocom Wireless Inc. (China), Quectel (China), and Sequans (France) These companies adopted strategies such as service launches, expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their market presence in the 5G in healthcare market. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 25)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 30)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION: 5G IN HEALTHCARE MARKET
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE FROM 5G IOT VENDORS
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY (DEMAND SIDE): DEMAND-SIDE MARKET ESTIMATIONS THROUGH APPLICATION/USE CASES
FIGURE 8 CAGR PROJECTIONS: OVERALL 5G IN HEALTHCARE MARKET
2.2.1 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET RANKING ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: 5G IN HEALTHCARE MARKET
2.7 LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 10 5G IN HEALTHCARE MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 5G IN HEALTHCARE MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 5G IN HEALTHCARE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE 5G IN HEALTHCARE MARKET
4 PREMIUM INSIGHTS (Page No. - 47)
4.1 5G IN HEALTHCARE MARKET OVERVIEW
FIGURE 14 RISING ADOPTION OF 5G-ENABLED WEARABLE MEDICAL DEVICES FOR REAL-TIME REMOTE PATIENT MONITORING TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: 5G IN HEALTHCARE MARKET, BY END USER AND COUNTRY (2020)
FIGURE 15 HEALTHCARE PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020
4.3 5G IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 JAPAN TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
4.4 REGIONAL MIX: 5G IN HEALTHCARE MARKET (2019−2026)
FIGURE 17 ASIA PACIFIC WILL DOMINATE THE 5G IN HEALTHCARE MARKET DURING THE FORECAST PERIOD
4.5 5G IN HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 51)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of telehealth and robotics surgery due to COVID-19
5.2.1.2 Rising adoption of 5G-enabled wearable medical devices for real-time remote patient monitoring
FIGURE 19 SMARTPHONE USERS AND PENETRATION WORLDWIDE, 2016–2021
5.2.1.3 Ability of 5G technology to transmit large patient data files quickly
5.2.1.4 Advancements in telecommunication
5.2.1.5 Availability of low-cost sensors
5.2.2 RESTRAINTS
5.2.2.1 High cost of deployment of the 5G network
5.2.3 OPPORTUNITIES
5.2.3.1 Role of AI in 5G healthcare
5.2.3.2 High reliability and low latency 5G networks to accelerate a new wave of healthcare applications
5.2.4 CHALLENGES
5.2.4.1 Delay in spectrum harmonization across geographies
5.2.4.2 Data breach and security concerns
FIGURE 20 US: NUMBER OF DATA BREACHES (2005–2020)
6 INDUSTRY INSIGHTS (Page No. - 58)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 RISING DEMAND FOR 5G TECHNOLOGY ACROSS THE HEALTHCARE CONTINUUM
FIGURE 21 TELECOM OPERATOR REVENUE POTENTIAL IN ADDRESSING HEALTHCARE INDUSTRY DIGITALIZATION WITH 5G IN 2026
6.2.2 5G-ENABLED INTERNET OF MEDICAL THINGS (IMOT)
FIGURE 22 5G HEALTHCARE USE CASES
6.2.3 5G-ENABLED HEALTHCARE TRAINING AND THERAPEUTIC & REHABILITATIVE USES FOR AR/VR
6.2.4 PRIVATE 5G NETWORKS
6.3 TECHNOLOGY ANALYSIS
6.3.1 INTRODUCTION
FIGURE 23 COMPARISON OF 5G TECHNOLOGY SPECIFICATIONS TO OTHER WIRELESS PROTOCOLS
6.3.2 WI-FI
6.3.3 WIMAX
6.3.4 NETWORK SLICING IN RADIO ACCESS NETWORK
6.3.5 NETWORK SLICING IN CORE NETWORK
6.3.6 NETWORK SLICING IN TRANSPORT NETWORK
6.3.7 SMALL CELL NETWORKS
6.3.8 LONG-TERM EVOLUTION NETWORKS
6.3.9 CITIZENS BROADBAND RADIO SERVICES
6.3.10 MULTEFIRE
6.4 REGULATORY IMPLICATIONS
6.4.1 GENERAL DATA PROTECTION REGULATION
6.4.2 CALIFORNIA CONSUMER PRIVACY ACT
6.4.3 PAYMENT CARD INDUSTRY DATA SECURITY STANDARD
6.4.4 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT
6.4.5 DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE
6.4.6 HEALTH LEVEL SEVEN
6.4.7 GRAMM-LEACH-BLILEY ACT
6.4.8 SARBANES-OXLEY ACT
6.4.9 SOC 2
6.4.10 COMMUNICATIONS DECENCY ACT
6.4.11 DIGITAL MILLENNIUM COPYRIGHT ACT
6.4.12 ANTI-CYBERSQUATTING CONSUMER PROTECTION ACT
6.4.13 LANHAM ACT
6.5 PRICING ANALYSIS
TABLE 4 5G IN HEALTHCARE MARKET: PRICING ANALYSIS
6.6 CASE STUDY ANALYSIS
6.6.1 CHINA MOBILE LIMITED
6.6.2 AT&T
6.7 ECOSYSTEM ANALYSIS
TABLE 5 5G IN HEALTHCARE MARKET: ECOSYSTEM MAPPING
FIGURE 24 5G IN HEALTHCARE MARKET: ECOSYSTEM MARKET MAP
6.7.1 5G TELECOM OPERATORS
6.7.2 5G MOBILE SENSOR/CHIPSET TECHNOLOGY PROVIDERS
6.7.3 5G MOBILE DEVICE MANUFACTURERS
6.7.4 END USER/APPLICATION/USE CASES
6.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES ANALYSIS
6.8.1 INTENSITY OF COMPETITIVE RIVALRY
6.9 COVID-19 IMPACT ON THE 5G IN HEALTHCARE MARKET
6.10 PATENT ANALYSIS
TABLE 7 PATENTS IN 5G IN HEALTHCARE MARKET
FIGURE 25 TOTAL NO. OF PATENTS FILED BY PLAYERS
FIGURE 26 FILING TREND
7 5G IN HEALTHCARE MARKET, BY COMPONENT (Page No. - 78)
7.1 INTRODUCTION
TABLE 8 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
7.2 HARDWARE
7.2.1 HARDWARE IS THE LARGEST COMPONENT SEGMENT OF THE 5G IN HEALTHCARE MARKET
TABLE 9 5G IN HEALTHCARE MARKET FOR HARDWARE, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 SERVICES
7.3.1 SERVICES HELP END USERS EFFECTIVELY DESIGN AND OPERATE NETWORK INFRASTRUCTURE TO GAIN DESIRABLE BUSINESS OUTCOMES
7.3.2 PROFESSIONAL SERVICES
7.3.3 MANAGED SERVICES
TABLE 10 5G IN HEALTHCARE MARKET FOR SERVICES, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 CONNECTIVITY
7.4.1 5G CONNECTIVITY TO BRING STRONG FOUNDATION FOR INTERNET OF THINGS USE CASES
TABLE 11 5G IN HEALTHCARE MARKET FOR CONNECTIVITY, BY COUNTRY, 2019–2026 (USD MILLION)
8 5G IN HEALTHCARE MARKET, BY APPLICATION (Page No. - 84)
8.1 INTRODUCTION
TABLE 12 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
8.2 CONNECTED MEDICAL DEVICES
8.2.1 CONNECTED MEDICAL DEVICES IS THE LARGEST APPLICATION SEGMENT OF THE 5G IN HEALTHCARE MARKET
TABLE 13 5G IN HEALTHCARE MARKET FOR CONNECTED MEDICAL DEVICES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 REMOTE PATIENT MONITORING
8.3.1 PATIENT READMISSION RATE HAS BEEN REDUCING DUE TO THE AVAILABILITY OF PATIENT MONITORING KITS AT HIGH-SPEED 5G CONNECTIVITY
TABLE 14 5G IN HEALTHCARE MARKET FOR REMOTE PATIENT MONITORING, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 ASSET TRACKING FOR MEDICAL DEVICES
8.4.1 5G IOT ENABLES HEALTHCARE COMPANIES TO DEPLOY EFFICIENT IOT APPLICATIONS, WHICH HELPS THEM TRACK THEIR ASSETS IN REAL-TIME
TABLE 15 5G IN HEALTHCARE MARKET FOR ASSET TRACKING FOR MEDICAL DEVICES, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 AR/VR
8.5.1 5G-POWERED AR AND VR ENABLES HEALTHCARE PROVIDERS TO VISUALIZE PROCEDURES IN AN ENGAGING, LEARNING-BY-DOING PRACTICE THAT WILL ENHANCE THEIR MEDICAL EDUCATION
TABLE 16 5G IN HEALTHCARE MARKET FOR AR/VR, BY COUNTRY, 2019–2026 (USD MILLION)
8.6 CONNECTED AMBULANCE
8.6.1 CONNECTED AMBULANCE IS EMPOWERED BY 5G’S HIGH BANDWIDTH, LOW LATENCY, AND ULTRA-RELIABLE CONNECTIVITY
TABLE 17 5G IN HEALTHCARE MARKET FOR CONNECTED AMBULANCE, BY COUNTRY, 2019–2026 (USD MILLION)
9 5G IN HEALTHCARE MARKET, BY END USER (Page No. - 92)
9.1 INTRODUCTION
TABLE 18 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 HEALTHCARE PROVIDERS
9.2.1 RISING NEED TO IMPROVE THE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST THE USE OF 5G IN HEALTHCARE
TABLE 19 5G IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 HEALTHCARE PAYERS
9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO DRIVE THE DEMAND FOR 5G IN HEALTHCARE
TABLE 20 5G IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2019–2026 (USD MILLION)
9.4 OTHER END USERS
TABLE 21 5G IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
10 5G IN HEALTHCARE MARKET, BY REGION (Page No. - 97)
10.1 INTRODUCTION
TABLE 22 5G IN HEALTHCARE MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: 5G IN HEALTHCARE MARKET SNAPSHOT
TABLE 23 APAC: 5G IN HEALTHCARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 24 APAC: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 25 APAC: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 26 APAC: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 CHINA
10.2.1.1 China dominates the APAC 5G in healthcare market
TABLE 27 CHINA: MACROECONOMIC INDICATORS
TABLE 28 CHINA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 29 CHINA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 30 CHINA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.2 JAPAN
10.2.2.1 Japan has a strong base of technologically advanced healthcare verticals that offer multiple opportunities for the growth of the 5G network
TABLE 31 JAPAN: MACROECONOMIC INDICATORS
TABLE 32 JAPAN: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 33 JAPAN: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 34 JAPAN: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.3 SOUTH KOREA
10.2.3.1 Increased spending on geriatric health and coverage for major chronic diseases to support market growth in South Korea
TABLE 35 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 36 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 37 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 38 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.4 AUSTRALIA
10.2.4.1 Favorable R&D tax benefits offered in the country to drive market growth
TABLE 39 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 40 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 41 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 42 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.5 REST OF ASIA PACIFIC
TABLE 43 ROAPAC: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 44 ROAPAC: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 45 ROAPAC: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3 NORTH AMERICA
FIGURE 28 NORTH AMERICA: 5G IN HEALTHCARE MARKET SNAPSHOT
TABLE 46 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 47 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 48 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 US
10.3.1.1 The US dominates the North American 5G in healthcare market
TABLE 50 US: MACROECONOMIC INDICATORS
TABLE 51 US: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 52 US: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 53 US: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.2 CANADA
10.3.2.1 Deployment of digital services to drive market growth
TABLE 54 CANADA: MACROECONOMIC INDICATORS
TABLE 55 CANADA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 56 CANADA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 57 CANADA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4 EUROPE
TABLE 58 EUROPE: 5G IN HEALTHCARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 GERMANY
10.4.1.1 Germany accounted for the largest share of the European 5G in healthcare market in 2020
TABLE 62 GERMANY: MACROECONOMIC INDICATORS
TABLE 63 GERMANY: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 64 GERMANY: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 65 GERMANY: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 UK
10.4.2.1 Government initiatives favoring the adoption of digitalization to drive market growth
TABLE 66 UK: MACROECONOMIC INDICATORS
TABLE 67 UK: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 68 UK: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 69 UK: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 REST OF EUROPE
TABLE 70 ROE: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 71 ROE: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 72 ROE: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 5G IN HEALTHCARE MARKET IN LATIN AMERICA IS IN THE NASCENT PHASE AND IS EXPECTED TO GROW AT A STEADY RATE IN THE FORECAST PERIOD
TABLE 73 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 74 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 75 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 RISING DEMAND FOR BETTER TECHNOLOGY-ENABLED MEDICAL DEVICES TO SUPPORT MARKET GROWTH
TABLE 76 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 78 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 132)
11.1 INTRODUCTION
FIGURE 29 KEY DEVELOPMENTS BY MAJOR PLAYERS BETWEEN JANUARY 2018 AND AUGUST 2021
11.2 COMPETITIVE BENCHMARKING
11.2.1 COMPONENT FOOTPRINT OF COMPANIES
11.2.2 REGIONAL FOOTPRINT OF COMPANIES
11.3 5G IN HEALTHCARE MARKET: R&D EXPENDITURE
FIGURE 30 R&D EXPENDITURE OF KEY PLAYERS IN THE 5G IN HEALTHCARE MARKET (2019 VS. 2020)
11.4 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 31 5G IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY MARKET PLAYERS (2020)
11.5 COMPETITIVE LEADERSHIP MAPPING
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 32 COMPETITIVE LEADERSHIP MAPPING: 5G IN HEALTHCARE MARKET, 2020
11.6 MARKET RANKING ANALYSIS
FIGURE 33 5G IN HEALTHCARE MARKET RANKING ANALYSIS, BY KEY PLAYER, 2020
11.7 COMPETITIVE SITUATION AND TRENDS
11.7.1 COMPONENT LAUNCHES
11.7.2 DEALS
11.7.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES (Page No. - 142)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 AT&T
TABLE 79 AT&T: BUSINESS OVERVIEW
FIGURE 34 AT&T: COMPANY SNAPSHOT (2020)
12.1.2 VERIZON
TABLE 80 VERIZON: BUSINESS OVERVIEW
FIGURE 35 VERIZON: COMPANY SNAPSHOT (2020)
12.1.3 ERICSSON
TABLE 81 ERICSSON: BUSINESS OVERVIEW
FIGURE 36 ERICSSON: COMPANY SNAPSHOT (2020)
12.1.4 T-MOBILE
TABLE 82 T-MOBILE: BUSINESS OVERVIEW
FIGURE 37 T-MOBILE: COMPANY SNAPSHOT (2020)
12.1.5 CHINA MOBILE LIMITED
TABLE 83 CHINA MOBILE LIMITED: BUSINESS OVERVIEW
FIGURE 38 CHINA MOBILE LIMITED: COMPANY SNAPSHOT (2020)
12.1.6 CISCO
TABLE 84 CISCO: BUSINESS OVERVIEW
FIGURE 39 CISCO: COMPANY SNAPSHOT (2020)
12.1.7 TELUS
TABLE 85 TELUS: BUSINESS OVERVIEW
FIGURE 40 TELUS: COMPANY SNAPSHOT (2020)
12.1.8 HUAWEI TECHNOLOGIES CO., LTD.
TABLE 86 HUAWEI TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW
FIGURE 41 HUAWEI TECHNOLOGIES CO., LTD.: COMPANY SNAPSHOT (2020)
12.1.9 TELIT
TABLE 87 TELIT: BUSINESS OVERVIEW
FIGURE 42 TELIT: COMPANY SNAPSHOT (2020)
12.1.10 ORANGE S.A.
TABLE 88 ORANGE S.A.: BUSINESS OVERVIEW
FIGURE 43 ORANGE S.A.: COMPANY SNAPSHOT (2020)
12.1.11 TELEFÓNICA
TABLE 89 TELEFÓNICA: BUSINESS OVERVIEW
FIGURE 44 TELEFÓNICA: COMPANY SNAPSHOT (2020)
12.1.12 SK TELECOM CO., LTD.
TABLE 90 SK TELECOM CO., LTD.: BUSINESS OVERVIEW
FIGURE 45 SK TELEKOM CO., LTD.: COMPANY SNAPSHOT (2020)
12.1.13 SAMSUNG
TABLE 91 SAMSUNG: BUSINESS OVERVIEW
FIGURE 46 SAMSUNG: COMPANY SNAPSHOT (2020)
12.1.14 BT GROUP
TABLE 92 BT GROUP: BUSINESS OVERVIEW
FIGURE 47 BT GROUP: COMPANY SNAPSHOT (2020)
12.1.15 DEUTSCHE TELEKOM
TABLE 93 DEUTSCHE TELEKOM AG: BUSINESS OVERVIEW
FIGURE 48 DEUTSCHE TELEKOM AG: COMPANY SNAPSHOT (2020)
12.1.16 VODAFONE
TABLE 94 VODAFONE: BUSINESS OVERVIEW
FIGURE 49 VODAFONE: COMPANY SNAPSHOT (2020)
12.1.17 NOKIA
TABLE 95 NOKIA: BUSINESS OVERVIEW
FIGURE 50 NOKIA: COMPANY SNAPSHOT (2020)
12.1.18 NEC CORPORATION
TABLE 96 NEC CORPORATION: BUSINESS OVERVIEW
FIGURE 51 NEC CORPORATION: COMPANY SNAPSHOT (2020)
12.1.19 QUALCOMM
TABLE 97 QUALCOMM: BUSINESS OVERVIEW
FIGURE 52 QUALCOMM: COMPANY SNAPSHOT (2020)
12.1.20 NTT DOCOMO
TABLE 98 NTT DOCOMO: BUSINESS OVERVIEW
FIGURE 53 NTT DOCOMO: COMPANY SNAPSHOT (2020)
12.2 OTHER PLAYERS
12.2.1 SIERRA WIRELESS
12.2.2 QUECTEL
12.2.3 FIBOCOM
12.2.4 SWISSCOM
12.2.5 SEQUANS
12.2.6 AIRTEL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 204)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved four major activities for estimating the current size of the 5G in healthcare market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Revenue Share Analysis, bottom-up and top-down approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.
Secondary Research
In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources include annual reports, press releases and investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the real-world evidence solutions market. Primary sources from the demand side include experts from pharma and biopharma companies, experts from food industry and research centers. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on the key industry trends and key market dynamics, such as market drivers, restraints, challenges, and opportunities.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the real-world evidence solutions market was arrived at after data triangulation from two different approaches, as mentioned below.
Approach to calculate the revenue of different players in the 5G in healthcare market
The size of the 5G in healthcare market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global 5G in healthcare market was derived.
Approach to derive the market size and estimate market growth
The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Objectives of the Study
- To define, describe, and forecast the global 5G in healthcare market based on component, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to the individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa (along with the major countries in these regions)
- To profile the key market players and comprehensively analyze their market shares and core competencies2 in the 5G in healthcare market
- To track and analyze competitive developments such as business expansions, partnerships, agreements, collaborations, acquisitions, and product/service launches in the global 5G in healthcare market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top companies
Geographic Analysis
- Further breakdown of the RoAPAC market into India, New Zealand, Hong Kong, Singapore, and other countries
- Further breakdown of the RoE market into France, Italy, Russia, the Netherlands, Nordic countries, and other countries
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Growth opportunities and latent adjacency in 5G in Healthcare Market